Capricor Therapeutics Announces Collaboration with the National Institutes of Health for Clinical Trial of Novel Exosome-Based Multivalent Vaccine for SARS-CoV-2
Stock Information for LightPath Technologies Inc.
Loading
Please wait while we load your information from QuoteMedia.